Inventor
CHARO ISRAEL
US14 patents
Patents
14 patentsUS11045469B2Jun 29, 2021
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
CHEMOCENTRYX INC5 citations83
US11304952B2Apr 19, 2022
Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
CHEMOCENTRYX INC11 citations82
US10583131B2Mar 10, 2020
Methods of treating pancreatic cancer
CHEMOCENTRYX INC8 citations82
US10398685B2Sep 3, 2019
Methods of treating pancreatic cancer
CHEMOCENTRYX INC6 citations82
US10251888B2Apr 9, 2019
Method of treating pancreatic cancer
CHEMOCENTRYX INC9 citations82
US11020394B2Jun 1, 2021
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
CHEMOCENTRYX INC1 citations72
US10682344B2Jun 16, 2020
Method of treating liver fibrosis
CHEMOCENTRYX INC2 citations72
US11890276B2Feb 6, 2024
Methods of treating pancreatic cancer
CHEMOCENTRYX INC1 citations71
US11116756B2Sep 14, 2021
Methods of treating pancreatic cancer
CHEMOCENTRYX INC1 citations71
US10195188B2Feb 5, 2019
Method of treating pancreatic cancer
CHEMOCENTRYX INC2 citations71
US10568870B2Feb 25, 2020
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
CHEMOCENTRYX INC2 citations69
US11883391B2Jan 30, 2024
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
CHEMOCENTRYX INC0 citations62
US11357760B2Jun 14, 2022
Method of treating liver fibrosis
CHEMOCENTRYX INC0 citations61
US11744822B2Sep 5, 2023
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
CHEMOCENTRYX INC0 citations59